lorazepam has been researched along with physostigmine in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (28.57) | 18.7374 |
| 1990's | 2 (28.57) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (28.57) | 24.3611 |
| 2020's | 1 (14.29) | 2.80 |
| Authors | Studies |
|---|---|
| Chang, G; El-Kattan, A; Miller, HR; Obach, RS; Rotter, C; Steyn, SJ; Troutman, MD; Varma, MV | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Doenicke, A; Fichte, K; Grote, B; Kugler, J; Laub, M; Ott, H; Suttmann, H; Zwisler, P | 1 |
| Domino, EF; Kothary, SP; Pandit, SK; Pandit, UA; Samra, SK | 1 |
| Shenoy, RS | 1 |
| Chu, J; Perrone, J; Stecker, MM | 1 |
| Baker, K; Heard, K; Janis, GC; Leonard, J; Mistry, RD; Ng, P; Wang, GS | 1 |
1 review(s) available for lorazepam and physostigmine
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
1 trial(s) available for lorazepam and physostigmine
| Article | Year |
|---|---|
A randomized trial comparing physostigmine vs lorazepam for treatment of antimuscarinic (anticholinergic) toxidrome.
Topics: Adolescent; Akathisia, Drug-Induced; Anti-Anxiety Agents; Delirium; Diphenhydramine; Double-Blind Method; Female; Humans; Length of Stay; Lorazepam; Male; Muscarinic Antagonists; Physostigmine; Treatment Outcome | 2021 |
5 other study(ies) available for lorazepam and physostigmine
| Article | Year |
|---|---|
Physicochemical space for optimum oral bioavailability: contribution of human intestinal absorption and first-pass elimination.
Topics: Administration, Oral; Biological Availability; Humans; Intestinal Absorption; Pharmaceutical Preparations | 2010 |
[The antagonistic effect of physostigmine on sedation by lormetazepam (author's transl)].
Topics: Anti-Anxiety Agents; Arousal; Benzodiazepines; Electroencephalography; Humans; Lorazepam; Male; Physostigmine; Sleep Stages; Statistics as Topic; Time Factors | 1981 |
Physostigmine fails to reverse clinical, psychomotor, or EEG effects of lorazepam.
Topics: Adult; Anti-Anxiety Agents; Brain; Cardiovascular Diseases; Double-Blind Method; Electroencephalography; Female; Gastrointestinal Diseases; Glycopyrrolate; Humans; Hypnotics and Sedatives; Lorazepam; Male; Memory; Physostigmine; Psychomotor Performance | 1983 |
Pitfalls in the treatment of jimsonweed intoxication.
Topics: Adolescent; Contraindications; Datura stramonium; Drug Therapy, Combination; Haloperidol; Humans; Lorazepam; Male; Physostigmine; Plants, Medicinal; Plants, Toxic; Psychoses, Substance-Induced; Substance-Related Disorders | 1994 |
Viral encephalitis masquerading as a fulminant anticholinergic toxidrome.
Topics: Adult; Anti-Anxiety Agents; Cholinergic Antagonists; Cholinesterase Inhibitors; Diagnosis, Differential; Diencephalon; Drug Therapy, Combination; Electroencephalography; Encephalitis, Viral; Female; Humans; Lorazepam; Magnetic Resonance Imaging; Physostigmine; Poisoning | 1997 |